Coherent (COHR) Form 144 Filed for 7,136-Share Sale on NYSE
Rhea-AI Filing Summary
Coherent Corp. Form 144 filing (COHR) reports a proposed sale of 7,136 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $679,347.20. The filing lists total shares outstanding of 155,805,474. The securities were acquired as Restricted Stock Units on 08/28/2025 and the approximate sale date is 08/29/2025. The filer certifies no undisclosed material adverse information and provides broker details for the transaction. No other sales in the past three months are reported.
Positive
- Timely and specific disclosure of proposed sale details including broker, number of shares, aggregate value, and sale date
- Use of an established broker (Morgan Stanley Smith Barney) for the transaction provides standard market execution channels
- Filer affirms no undisclosed material adverse information, meeting the certification requirement on the form
Negative
- Immediate sale after vesting: securities were acquired as RSUs on 08/28/2025 and the approximate sale date is 08/29/2025, which may prompt investor questions
- Concentration timing: sale occurs one day after acquisition, potentially raising governance or optics concerns despite being disclosed
Insights
TL;DR: Small, disclosed insider sale of recently vested RSUs executed through a major broker; limited market impact given size.
The filing documents a routine sale of 7,136 common shares with an aggregate value of $679,347.20 executed via Morgan Stanley Smith Barney. The shares were acquired as restricted stock units the day prior to the proposed sale, indicating a near-immediate disposition of vested equity. Given the reported outstanding share count of 155,805,474, this block represents a very small fraction of capitalization and is unlikely to materially affect market valuation. The filing conforms to Rule 144 disclosure requirements and shows no prior sales in the past three months.
TL;DR: Governance process appears followed; rapid sale after vesting is transparent but may prompt standard investor questions.
The filer used the prescribed Form 144 notice and included broker and acquisition details, satisfying procedural disclosure obligations. The near-immediate sale of RSUs (acquired 08/28/2025, sale 08/29/2025) is explicitly stated, which is permissible but may draw attention from governance-minded investors regarding personal liquidity needs or tax planning. The signer also affirms absence of undisclosed material adverse information. No evidence in this filing of coordinated or aggregated sales by related parties in the prior three months.